text: "Treatment-emergent autoimmune hepatitis with positive anti-nuclear antibodies developed after cycle 3."
expected_vale_issues:
  - rule: CSR.safety.severity
    message: "Use CTCAE grading terminology: specify liver function grades"
  - rule: CSR.safety.reporting
    message: "Include immunological parameters"
  - rule: CSR.laboratory.reporting
    message: "Required laboratory reporting element missing: autoimmune markers"
expected_llm_feedback:
  - "Report ANA titer and pattern"
  - "Include complete liver panel"
  - "Report immunoglobulin levels"
  - "Detail steroid response"
  - "Include liver biopsy findings"
  - "Report other autoantibodies"
